Scholar Rock Holding SRRK 深 滬
等待開盤 12-13 09:30:00 美东时间
46.87
+0.040
+0.09%
華盛通- 最 高48.28
- 今 開47.00
- 成交量 193.43万股
- 最 低 46.04
- 昨 收 46.83
- 總市值 45.05亿
- 52周最高 48.28
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 22.71
- 委 比 -23.40%
- 總股本 9612.73万
- 歷史最高 70.00
- 量 比 1.46
- 振 幅 4.78%
- 歷史最低 4.325
- 每 手 1
- 風險率 5.02%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多FDA OKs Novartis SMA Treatment As First Gene Therapy Option For Kids, Teens And Adults
Novartis wins FDA approval for Itvisma, a one-time gene therapy offering broader SMA treatment with sustained motor function improvements.
11-25 23:14
美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价
今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元
11-19 11:01
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
11-18 15:28
美股周涨跌榜 | 新药取得重大突破！COGT周涨超126%；生物制药公司Cidara周涨逾108%，获默沙东收购
新药取得重大突破！COGT周涨超126%；生物制药公司Cidara周涨逾108%，获默沙东92亿美元收购；REAL周涨超26%，Q3业绩超预期>>
11-15 10:30
Why Is Scholar Rock Holding Stock Climbing Today?
Scholar Rock shares jump after the company strengthened its cash runway into 2027 and advanced launch preparations for its lead drug candidate, apitegromab.
11-15 02:49
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Dow Jones index falling more than 500 points o...
11-14 22:54
Scholar Rock Holding shares are trading higher. The company announced a $200 million equity offering.
Scholar Rock Holding shares are trading higher. The company announced a $200 mi...
11-14 22:30
Scholar Rock Announces $200M At-The-Market Offering
Scholar Rock Holding ( ($SRRK) ) just unveiled an update. Scholar Rock Holding ...
11-14 21:14
Scholar Rock Holds Constructive FDA Meeting for Apitegromab
Scholar Rock Holding ( ($SRRK) ) has provided an update. Scholar Rock reported ...
11-14 20:28
Scholar Rock Holding Q3 EPS $(0.90) Misses $(0.70) Estimate; Cash $369.6M
Scholar Rock Holding (NASDAQ:SRRK) reported quarterly losses of $(0.90) per share which missed the analyst consensus estimate of $(0.70) by 28.39 percent. This is a 36.36 percent decrease over losses of $(0.66) per share
11-14 20:03
